Clinical trials: Pancancer
Pancancer
Prospective Pathology Foundation Models
Histopathology remains the gold standard for disease diagnosis, yet faces challenges including pathologist shortages and diagnostic model limitations.
- Trial name
- NCT07157618
- Where
- 2 sites in China
- Volunteers
- 2,000 people
- Sponsor
- Nanfang Hospital, Southern Medical University
Pancancer
Prospective Real-World Study of Multimodal AI
This project proposes to collect prospective multimodal data-such as pathology, imaging, and clinical information-and to perform integrative analyses.
- Trial name
- NCT07269236
- Where
- 2 sites in China
- Volunteers
- 2,000 people
- Sponsor
- Nanfang Hospital, Southern Medical University
Pancancer
Retrospective Pathology Foundation Models
By integrating retrospective multimodal data such as pathology and imaging, AI technologies offer novel solutions for disease classification, tumor grading, histological and molecular subtyping, selection of chemotherapy…
- Trial name
- NCT07239297
- Where
- 2 sites in China
- Volunteers
- 2,000 people
- Sponsor
- Nanfang Hospital, Southern Medical University